|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/542 | (2006.01) |
| G01N 33/58 | (2006.01) | ||
| G01N 33/68 | (2006.01) | ||
| G01N 33/86 | (2006.01) |
| (11) | Number of the document | 2431741 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11009919.9 |
| Date of filing the European patent application | 2009-10-20 | |
| (97) | Date of publication of the European application | 2012-03-21 |
| (45) | Date of publication and mention of the grant of the patent | 2013-08-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 10725708 P | 2008-10-21 | US | |
| 24263409 P | 2009-09-15 | US |
| (72) |
Varadi, Katalin, AT
Schrenk, Gerald, AT
Rottensteiner, Hanspeter, AT
Turecek, Peter, AT
Weber, Alfred, AT
Anderle, Heinz, AT
Culbertson, Sean M., US
Fang, Zhihao, US
Zappe, Harold, US
Zhang, Ping, US
Bossard, Mary J., US
|
| (73) |
Baxter Healthcare SA,
Thurgauerstrasse 130, 8152 Glattpark (Opfikon),
CH
Baxter International Inc, One Baxter Parkway, Deerfield, IL 60015, US Nektar Therapeutics, 455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94158, US |
| (54) | Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation) |
| Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation) |